PubMed · 1990 · 79 citations · 0 references
MedicineHematologyImmunologyRegenerative MedicineStem Cell BiologyStem Cell TransplantationAutologous Stem Cell TransplantationEngraftment MonitoringHematopoietic Stem Cell TransplantationStem Cell MobilizationTransfusion SupportTransplant ImmunotherapyAutologous Hematopoietic Stem Cell MobilizationAutologous Stem Cell InfusionAutologous Stem Cell TherapyAutologous Transplant ConditioningCytokine Modulation TherapyStem Cell Mobilization PharmacotherapyTherapeutic Efficacy Assessment
The natural anticoagulants, protein C, protein S and antithrombin, were measured in 21 patients following bone marrow transplantation (BMT). The patients were divided into two groups, those with normal protein C concentration post-BMT and those with significantly reduced protein C concentrations; 12 cases fell into the second group. In addition there was an associated fall in protein S in this group of patients. In spite of the presumed hypercoagulable state only one patient developed overt veno-occlusive disease (VOD) of the liver and no other thrombotic events occurred. The fall in protein C and protein S was coincident with the peak incidence of VOD and is likely to be a contributing factor to the genesis of this condition. Only protein S measured pre-BMT was of predictive value in identifying patients likely to develop reduced levels of these anticoagulants post-BMT. Age, sex, diagnosis, type of conditioning and the pre-BMT measurement of protein C and antithrombin had no predictive value.